Work Injury In Connecticut Explained In HelloNation By Personal Injury Attorney Robert Elfont

Revenue crosses $20 billion mark with resilient growth of 3.1% in FY 26 in constant currency

Servier finalise l'acquisition de Day One Biopharmaceuticals

HelloNation Article Highlights Gum Disease Prevention With Insights From Periodontics Expert Dr. Brenda Pierce

Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA

Healthy Smart Mart™ Announces Expansion of Micro Market Model for 2026

12PanelNow Solidifies Position as Industry-Leading Direct Manufacturer of Serenity Drug Test Cups

Davidson Hospitality Group Selected to Manage Homestead Midway Utah

CREATE Medicines Doses First Patient in Phase 1/2 Study of MT-304, a First-in-Class Multi-immune In Vivo CAR Therapy Targeting HER2-Positive Solid Tumors

Mikart and Benuvia Announce Strategic Co-Marketing Partnership to Deliver End-to-End Controlled Substance Development and Finished Drug Product Manufacturing Solutions

WALOVI Signs Deals in Portugal & Spain, Moves from Scattered Footprints to Regional Deepening

High Levels of Gut Bacterial Wall Toxin Shown to Trigger Lupus Nephritis

SamaCare Launches First-of-Its-Kind Benchmarks for Medical Benefit Prior Authorization Performance

Infinitus Launches Studio, the First Healthcare-Specific No-Code AI Agent Builder

TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting

West Reports First-Quarter 2026 Results

Superdrug désigne Hanshow comme partenaire pour les étiquettes électroniques en rayon pour faire avancer la prochaine phase de numérisation du commerce de détail dans les secteurs de la santé et de la beauté

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Mabwell Initiates Phase III Clinical Study of its Nectin-4-Targeting ADC 9MW2821 for the Treatment of Triple-Negative Breast Cancer

SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations

DUAL-PATHWAY BLOCKADE THERAPY OFFERS HOPE FOR RARE, HARD-TO-TREAT GYNAECOLOGICAL CLEAR CELL CANCERS

WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics

AACR 2026 | Abbisko Therapeutics Showcases Six Research Advances Highlighting pan-KRAS, 4th Generation EGFR, and Synthetic Lethality Approaches

NEDHSA to Host Lincoln Parish NED Talk Road Tour in Grambling, LA: Focusing on Underage Drinking/Substance Abuse Workshop and Interactive Alcohol Simulation Experience

2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer

2026 ASCO Abstract Highlights | Innovent Announces Preliminary PoC data of IBI363 (PD-1/IL-2α-bias bispecific fusion protein) in Combination with Chemotherapy as First-line Treatment for Advanced NSCLC, Showing Encouraging Efficacy Signals and Favorable Safety

What drives multimillion-dollar medical claims? Sun Life report shows secondary health conditions, hospital stays and specialty drugs among key factors